These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 29615035)
1. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? Dal-Ré R; Janiaud P; Ioannidis JPA BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035 [TBL] [Abstract][Full Text] [Related]
2. Informing real-world practice with real-world evidence: the value of PRECIS-2. Neta G; Johnson KE BMC Med; 2018 May; 16(1):76. PubMed ID: 29783964 [TBL] [Abstract][Full Text] [Related]
3. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise. Palese A; Bevilacqua MG; Dante A; J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115 [TBL] [Abstract][Full Text] [Related]
4. Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial. Dal-Ré R J Eval Clin Pract; 2018 Feb; 24(1):258-261. PubMed ID: 28685913 [TBL] [Abstract][Full Text] [Related]
5. PRECIS-2 for retrospective assessment of RCTs in systematic reviews. Zwarenstein M; Thorpe K; Treweek S; Loudon K J Clin Epidemiol; 2020 Oct; 126():202-206. PubMed ID: 32565215 [TBL] [Abstract][Full Text] [Related]
6. Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study. Devos F; Foissac F; Bouazza N; Ancel PY; Tréluyer JM; Chappuy H J Clin Epidemiol; 2019 Dec; 116():18-25. PubMed ID: 31374332 [TBL] [Abstract][Full Text] [Related]
7. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review. Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028 [TBL] [Abstract][Full Text] [Related]
8. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol. Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809 [TBL] [Abstract][Full Text] [Related]
9. A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines. Dal-Ré R; Avendaño-Solà C; de Boer A; James SK; Rosendaal FR; Stephens R; Ioannidis JPA J Clin Epidemiol; 2019 Oct; 114():60-71. PubMed ID: 31212001 [TBL] [Abstract][Full Text] [Related]
10. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials. Dal-Ré R Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910 [TBL] [Abstract][Full Text] [Related]
11. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades. Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments. Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603 [TBL] [Abstract][Full Text] [Related]
13. Applying the PRECIS-2 tool for self-declared 'pragmatic' acupuncture trials: protocol for a systematic review. Lim J; Lee H; Kim YS BMJ Open; 2022 Apr; 12(4):e052861. PubMed ID: 35414545 [TBL] [Abstract][Full Text] [Related]
14. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437 [TBL] [Abstract][Full Text] [Related]
15. Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool. Dal-Ré R Eur J Clin Pharmacol; 2020 Aug; 76(8):1093-1102. PubMed ID: 32447436 [TBL] [Abstract][Full Text] [Related]
16. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems. Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered? Mansouri A; Cooper B; Shin SM; Kondziolka D J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006 [TBL] [Abstract][Full Text] [Related]
18. Thoughtful selection and use of scientific terms in clinical research: the case of 'pragmatic' trials. Dal-Ré R; Mentz RJ; Rosendaal FR J Investig Med; 2021 Jun; 69(5):1056-1058. PubMed ID: 33753535 [TBL] [Abstract][Full Text] [Related]
19. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review. Lim J; Lee H; Kim YS BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632 [TBL] [Abstract][Full Text] [Related]
20. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory. Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE Trials; 2016 Jan; 17():32. PubMed ID: 26772801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]